Skip to main content

. 1967 Feb;51(2):86–93. doi: 10.1136/bjo.51.2.86

Eye and skin changes in psychiatric patients treated with chlorpromazine.

PMCID: PMC506336 PMID: 6018911

Images in this article

Image
on p.90-1

Image
on p.90-1

Image
on p.90-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
BAN T. A., LEHMANN H. E. SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE. Can Psychiatr Assoc J. 1965 Apr;10:112–124. doi: 10.1177/070674376501000205. [DOI] [PubMed] [Google Scholar]
BARSA J. A., NEWTON J. C., SAUNDERS J. C. LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY. JAMA. 1965 Jul 5;193:10–12. doi: 10.1001/jama.1965.03090010016003. [DOI] [PubMed] [Google Scholar]
BOCK R., SWAIN J. OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY. Am J Ophthalmol. 1963 Nov;56:808–810. doi: 10.1016/0002-9394(63)92947-7. [DOI] [PubMed] [Google Scholar]
CAIRNS R. J., CAPOORE H. S., GREGORY I. D. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE. Lancet. 1965 Jan 30;1(7379):239–241. doi: 10.1016/s0140-6736(65)91524-2. [DOI] [PubMed] [Google Scholar]
CLOUD T. M., HAKIM R., GRIFFIN A. C. Photosensitization of the eye with methoxsalen. II. Chronic effects. Arch Ophthalmol. 1961 Nov;66:689–694. doi: 10.1001/archopht.1961.00960010691014. [DOI] [PubMed] [Google Scholar]
DELONG S. L., POLEY B. J., MCFARLANE J. R., Jr OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY. Arch Ophthalmol. 1965 May;73:611–617. doi: 10.1001/archopht.1965.00970030613003. [DOI] [PubMed] [Google Scholar]
FELDMAN P. E., FRIERSON B. D. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY. Am J Psychiatry. 1964 Aug;121:187–188. doi: 10.1176/ajp.121.2.187. [DOI] [PubMed] [Google Scholar]
GIACOBINI E., LASSENIUS B. Clorpromazinbehandling; biverkningar och komplikationer. Nord Med. 1954 Dec 2;52(49):1693–1699. [PubMed] [Google Scholar]
GREINER A. C., BERRY K. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. Can Med Assoc J. 1964 Mar 14;90:663–665. [PMC free article] [PubMed] [Google Scholar]
GREINER A. C., NICOLSON G. A., BAKER R. A. THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT. Can Med Assoc J. 1964 Sep 19;91:636–638. [PMC free article] [PubMed] [Google Scholar]
JONAS S. Miosis following administration of chlorpromazine and related agents. Am J Psychiatry. 1959 Mar;115(9):817–818. doi: 10.1176/ajp.115.9.817. [DOI] [PubMed] [Google Scholar]
POTTS A. M. The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol. 1962 Aug;1:522–530. [PubMed] [Google Scholar]
SINHA G. B., MITRA S. K. A case of acute chlorpromazine hydrochloride poisoning. J Indian Med Assoc. 1955 Apr 16;24(14):557–558. [PubMed] [Google Scholar]
Siddall J. R. The ocular toxic findings with prolonged and high dosage chlorpromazine intake. Arch Ophthalmol. 1965 Oct;74(4):460–464. doi: 10.1001/archopht.1965.00970040462005. [DOI] [PubMed] [Google Scholar]
VERREY F. Dégénérescence pigmentaire de la rétine d'origine médicamenteuse. Ophthalmologica. 1956 Apr-May;131(4-5):296–303. doi: 10.1159/000302845. [DOI] [PubMed] [Google Scholar]
WETTERHOLM D. H., SNOW H. L., WINTER F. C. A CLINICAL STUDY OF PIGMENTARY CHANGE IN CORNEA AND LENS IN CHRONIC CHLORPROMAZINE THERAPY. Arch Ophthalmol. 1965 Jul;74:55–56. doi: 10.1001/archopht.1965.00970040057013. [DOI] [PubMed] [Google Scholar]
ZELICKSON A. S., ZELLER H. C. A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE. JAMA. 1964 Apr 27;188:394–396. doi: 10.1001/jama.1964.03060300056018. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES